To screen ETFs by asset class, performance, yield and more, check out the
It's hard to get excited about a $400m company with an approved drug that treats 500 people in U.S. $
Lots of insiders exercising options and selling them soon after. That's exciting, if you're an insider.
the insurance companies,market,and RPTP need to agree on a lower cost some say its 250,000 dollars yr for treatment. Will take time
Add a reply...
Latest StockTalks »
people get RPTP breaking news and analysis by email alert.
Get email alerts on RPTP »
Raptor Pharmaceutical Corp.
Get latest price
From other sites
Raptor Pharmaceutical : Datalogic Congratulates ECR Software Corporation as Recipient of the Innovative Solution Award Presented by Retail Solution Provider Association
at 4-traders.com (Tue, 11:32AM)
Raptor Pharmaceutical : Provides Topline Results From Phase 2b CyNCh Study Evaluating RP103 in Pediatric Nonalcoholic Steatohepatitis
at 4-traders.com (Sep 15, 2015)
Raptor Pharmaceuticals (RPTP) in Focus: Stock Plunges 37.5%
at Zacks.com (Sep 15, 2015)
Raptor Pharmaceuticals (RPTP) in Focus: Stock Adds 5.8%
at Zacks.com (Aug 24, 2015)
RAPTOR PHARMACEUTICAL : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
at 4-traders.com (Aug 21, 2015)
Xignite quote data
© 2015 Seeking Alpha